AI Stock Analysis - Geovax Labs (GOVX)
Analysis generated May 29, 2026.
Geovax Labs is a clinical-stage biotechnology company focused on developing human vaccines and immunotherapies using its novel viral vector platform technology. The company has a strong emphasis on infectious diseases and cancer vaccines. Geovax's innovative approach leverages its unique technology to develop potentially lifesaving treatments.
Stock Alerts - Geovax Labs (GOVX)
 |
Geovax Labs | June 15 Price is up by 7.4% in the last 24h. |
|
Geovax Labs | June 12 Price is up by 8.5% in the last 24h. |
|
Geovax Labs | June 10 Price is down by -6.3% in the last 24h. |
|
Geovax Labs | June 9 Price is up by 9% in the last 24h. |
Download our app on iOS or Android to get future alerts delivered in real-time.
Alternative Data for Geovax Labs
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1 | Sign up | Sign up | Sign up |
| Sentiment | 79 | Sign up | Sign up | Sign up |
| Webpage traffic | 11,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2 | Sign up | Sign up | Sign up |
| Facebook Followers | 500 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 57 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 14,378 | Sign up | Sign up | Sign up |
| X Followers | 2,622 | Sign up | Sign up | Sign up |
| X Mentions | 6 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 93 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 27 | Sign up | Sign up | Sign up |
About Geovax Labs
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform.
| Price | $1.18 |
| Target Price | Sign up |
| Volume | 3,598,723 |
| Market Cap | $6.4M |
| Year Range | $1.05 - $15.11 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
D. Boral Capital Downgrades Geovax Labs to HoldFebruary 18 - Benzinga |
|
 |
Geovax Labs Inc trading halted, news pendingJanuary 9 - Thefly.com |
Ebola Virus Vaccine Market Outlook 2026-2034: Market Share, Growth Analysis and Forecasts by Vaccine Type, End User, Distribution Channel, Patient DemographicsMay 20 - GlobeNewswire |
|
 |
12 Health Care Stocks Moving In Wednesday's Pre-Market SessionFebruary 17 - Benzinga |
 |
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.February 13 - ChartMill |
|
Let's take a look at the stocks that are in motion in today's session.February 13 - ChartMill |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '26 | 0 | -34,000 | 34,000 | -4.4M | -4.6M | |
| Q4 '25 | 0 | 0 | 0 | -4.4M | 0 | |
| Q3 '25 | 0 | 17,000 | -17,000 | -6.3M | -6.3M | -0.310 |
| Q2 '25 | 850,000 | 0 | 850,000 | -5.4M | -5.4M | -0.350 |
| Q1 '25 | 1.6M | 17,000 | 1.6M | -5.4M | -5.3M | -0.450 |
Insider Transactions View All
| SPENCER JOHN N JR filed to buy 21,402 shares at $0.5. October 20 '25 |
| McKee Kelly T. Jr. filed to buy 3,494 shares at $0.7. August 8 '25 |
| Sharkey John W. filed to buy 6,191 shares at $1. April 10 '25 |
| SPENCER JOHN N JR filed to buy 11,402 shares at $1. April 11 '25 |
| DODD DAVID A filed to buy 36,661 shares at $1.1. April 1 '25 |
Similar companies
Read more about Geovax Labs (GOVX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews & linkedin employees.
FAQ - Geovax Labs
The Market Cap of Geovax Labs is $6.4M.
Currently, the price of one share of Geovax Labs stock is $1.18.
The GOVX stock price chart above provides a comprehensive visual representation of Geovax Labs' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Geovax Labs shares. Our platform offers an up-to-date GOVX stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Geovax Labs (GOVX) does not offer dividends to its shareholders. Investors interested in Geovax Labs should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Geovax Labs are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
